ResMed
Precio: 192.39Empresa y modelo de negocio
ResMed is a healthcare company specializing in cloud-connected devices and software solutions for people with sleep apnea and chronic obstructive pulmonary disease (COPD). Its core products include continuous positive airway pressure (CPAP) devices, masks, and cloud-based software for patient management. The company operates primarily in the sleep and respiratory care segments, with major revenue sources stemming from device sales, software subscriptions, and related accessories.
Perfil de inversión
The investment profile of ResMed is more aligned with balanced investors, given its moderate growth potential and dividend yield. The company offers a steady revenue stream while also providing some income through dividends. However, the elevated risk factors suggest caution for those seeking aggressive growth.
Métricas fundamentales
- EPS (TTM) — ganancias por acción de los últimos 12 meses, $
- 10.38 OK
- Ingresos QoQ — crecimiento trimestral de ingresos
- 0.6% ≈
- Sorpresa EPS
- 2.5% en línea
- Volatilidad 20d
- 2.1% estable
- Rendimiento de dividendos
- 1.3% moderado última fecha ex-div.: 2026-05-14
Seguir en portafolio
Gráfico de precio
| Fecha | Antes | Después | Razón |
|---|---|---|---|
| 2026-06-03 02:51 | Mantener | Vender | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:49 | Vender | Mantener | Weak momentum and mixed fundamentals suggest caution. |
| 2026-05-08 15:18 | — | Vender | Weak momentum and high risk overshadow potential upside. |
| Fecha | Analista | Acción | Objetivo | Precio entonces |
|---|---|---|---|---|
| 2026-05-01 12:52 | Robert W. Baird | Objetivo reducido | 254 → 225 | 203.87 |
| 2026-04-27 10:21 | KeyBanc | Objetivo reducido | 302 → 290 | 219.85 |
| 2026-04-13 14:44 | Evercore ISI | Objetivo reducido | 300 → 255 | 228.33 |
Nada todavía